Follow-The-Filings

Featured 13F manager

DME Capital Management David Einhorn

New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2

  • $3.9B
  • 46 holds
  • 2026 Q2
  • +22.5% QoQ
  • Top 5 38.2%

David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.

Portfolio

2026 Q2 · filed 8/14/2026 · 46 long · top 12 shown

top 5 38.2% · top 10 52.8%

AUM over time

2026 Q2 $3.9B +22.5% QoQ
2021 Q3 · $1.5B 2021 Q3 · $1.5B
Q3 2021
2021 Q4 · $1.7B · +17.2% QoQ 2021 Q4 · $1.7B · +17.2% QoQ
Q4
2022 Q1 · $1.6B · −10.0% QoQ 2022 Q1 · $1.6B · −10.0% QoQ
Q1 2022
2022 Q2 · $1.3B · −18.3% QoQ 2022 Q2 · $1.3B · −18.3% QoQ
Q2
2022 Q3 · $1.4B · +9.8% QoQ 2022 Q3 · $1.4B · +9.8% QoQ
Q3
2022 Q4 · $1.4B · +2.3% QoQ 2022 Q4 · $1.4B · +2.3% QoQ
Q4
2023 Q1 · $1.8B · +27.4% QoQ 2023 Q1 · $1.8B · +27.4% QoQ
Q1 2023
2023 Q2 · $2.1B · +15.9% QoQ 2023 Q2 · $2.1B · +15.9% QoQ
Q2
2023 Q3 · $1.8B · −17.4% QoQ 2023 Q3 · $1.8B · −17.4% QoQ
Q3
2023 Q4 · $2B · +16.3% QoQ 2023 Q4 · $2B · +16.3% QoQ
Q4
2024 Q1 · $2.2B 2024 Q1 · $2.2B
Q1 2024
2024 Q2 · $2B · −6.5% QoQ 2024 Q2 · $2B · −6.5% QoQ
Q2
2024 Q3 · $2.4B · +17.6% QoQ 2024 Q3 · $2.4B · +17.6% QoQ
Q3
2024 Q4 · $1.9B · −19.1% QoQ 2024 Q4 · $1.9B · −19.1% QoQ
Q4
2025 Q1 · $2B · +1.5% QoQ 2025 Q1 · $2B · +1.5% QoQ
Q1 2025
2025 Q2 · $2.3B · +17.8% QoQ 2025 Q2 · $2.3B · +17.8% QoQ
Q2
2025 Q3 · $2.5B · +9.3% QoQ 2025 Q3 · $2.5B · +9.3% QoQ
Q3
2025 Q4 · $2.8B · +12.1% QoQ 2025 Q4 · $2.8B · +12.1% QoQ
Q4
2026 Q1 · $3.2B · +12.0% QoQ 2026 Q1 · $3.2B · +12.0% QoQ
Q1 2026
2026 Q2 · $3.9B · +22.5% QoQ 2026 Q2 · $3.9B · +22.5% QoQ
Q2

Book

2024 Q1 2023 Q4 · filed 15 May · long equity

GRBK - Green Brick Partners 28.86%, was 28.92% Reduce −8.2% 10,467,383 $60.23 $630M −937,500 +$38M
BHF - Brighthouse Finl 7.13%, was 7.86% Reduce −0.7% 3,021,763 $51.54 $156M −21,860 −$5M
KD - Kyndryl 6.58%, was 6.45% Add +3.9% 6,605,059 $21.76 $144M +248,990 +$12M
CEIXEUR - Consol Energy 6.29%, was 10.34% Reduce −22.1% 1,640,750 $83.76 $137M −464,827 −$74M
ALITEUR - Alight · CL A 5.20%, was 3.85% Add +24.7% 11,527,930 $9.85 $114M +2,286,260 +$35M
THC - Tenet Healthcare 4.28%, was 4.86% Reduce −32.3% 890,630 $105.11 $94M −425,340 −$6M
ODP1 - The Odp 4.15%, was 4.81% Reduce −2.1% 1,710,580 $53.05 $91M −37,520 −$8M
PENN - Penn Entertainment 3.80% New 4,554,710 $18.21 $83M +4,554,710 +$83M
LIVN - Livanova 3.41%, was 3.11% Add +8.4% 1,332,804 $55.94 $75M +103,488 +$11M
TECK - Teck Resources · CL B 3.25% Hold 1,552,063 $45.78 $71M — —
VTRS - Viatris 2.47%, was 1.77% Add +34.6% 4,517,620 $11.94 $54M +1,161,850 +$18M
PKG - Graphic Packaging 2.40%, was 3.05% Reduce −29.2% 1,796,130 $29.18 $52M −739,970 −$10M
GLD - Spdr Gold Tr 2.32%, was 3.61% Reduce −36.3% 246,671 $205.72 $51M −140,273 −$23M
HPQ - HP 2.24% New 1,615,960 $30.22 $49M +1,615,960 +$49M
DHT — 2.12%, was 1.81% Add +6.5% 4,024,340 $11.50 $46M +244,460 +$9M
ROIV - Roivant Sciences 2.02% New 4,190,490 $10.54 $44M +4,190,490 +$44M
FCNCA - First Ctzns Bancshares · CL A 1.88%, was 1.72% Add +1.4% 25,160 $1,635 $41M +340 +$6M
WFRD - Weatherford Intl 1.68%, was 2.18% Reduce −30.5% 317,477 $115.42 $37M −139,128 −$8M
LBTYA - Liberty Global · CL A 1.58% New 2,041,580 $16.92 $35M +2,041,580 +$35M
SDRL - Seadrill 2021 1.31%, was 1.26% Add +4.7% 569,405 $50.30 $29M +25,470 +$3M
AER - Aercap 1.27%, was 0.91% Add +27.6% 319,050 $86.91 $28M +69,050 +$9M
NPWR - Net Power · CL A 1.02%, was 1.48% Reduce −34.5% 1,959,280 $11.39 $22M −1,032,830 −$8M
RSP — 0.85% Reduce −1.6% 182,511 $101.57 $19M −3,010 +$1M
XAR - Spdr Ser Tr 0.82%, was 0.86% Reduce −1.6% 127,557 $140.51 $18M −2,110 +$364K
KVUE - Kenvue 0.70%, was 0.58% Add +27.6% 707,740 $21.46 $15M +153,250 +$3M
COYA - Coya Therapeutics 0.58% Hold 1,274,026 $9.92 $13M — —
GPRO - Gopro · CL A 0.29% Hold 2,823,100 $2.23 $6M — —
LKFT - Galapagos 0.24%, was 0.32% Reduce −1.7% 159,828 $32.20 $5M −2,750 −$1M
TEVA - Teva Pharmaceutical Inds 0.21%, was 0.14% Add +21.0% 324,850 $14.11 $5M +56,380 +$2M
OIH - Vaneck ETF Trust 0.17%, was 0.14% Add +21.0% 11,220 $336.33 $4M +1,950 +$904K
SHC - Sotera Health 0.16%, was 0.28% Reduce −10.9% 300,110 $12.01 $4M −36,860 −$2M
GDX - Vaneck ETF Trust 0.16% New 111,390 $31.62 $4M +111,390 +$4M
Danimer Scientific · CL A 0.14% Hold 2,734,580 $1.09 $3M — —
GANX - Gain Therapeutics 0.10% Reduce −3.8% 566,130 $3.77 $2M −22,280 +$213K
CLVT - Clarivate 0.10% New 279,560 $7.43 $2M +279,560 +$2M
FCG - First Tr Exchange-Traded Fd 0.09%, was 0.07% Add +21.0% 70,830 $27.44 $2M +12,290 +$522K
IVZ - Invesco Actvely Mngd Etc Fd 0.07%, was 0.06% Add +21.0% 117,360 $13.87 $2M +20,370 +$338K
TLIS - Talis Biomedical 0.06% Hold 149,052 $8.75 $1M — —
NUVB - Nuvation Bio · CL A 0.01% Hold 34,995 $3.64 $127K — —
OHRPEUR - Neubase Therapeutics 0.00% Hold 136,350 $0.4499 $61K — —

Exits / last held

Not current holdings · last reported size, unchanged · gone vs 2023 Q4

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
GPOR - Gulfport Energy 1.45% Exit 0 $133.20 $30M −222,970 −$30M
HRI - HERC 0.99% Exit 0 $148.89 $20M −135,610 −$20M
FHN - First Horizon 0.95% Exit 0 $14.16 $20M −1,377,090 −$20M
NYCBEUR - New York Cmnty Bancorp 0.91% Exit 0 $10.23 $19M −1,828,730 −$19M

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end — not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2023 Q4. Click column headers to sort · click New / Hold / Add / Reduce to promote that move type to the top. Exit opens the last-held block below.

Filings history

20 periods · normalized AUM · open a period for holdings

Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 46 $3.9B +22.5% 13F-HR 8/14/2026 000117266126003786
2026 Q1 45 $3.2B +12.0% 13F-HR 5/15/2026 000117266126002341
2025 Q4 41 $2.8B +12.1% 13F-HR 2/17/2026 000117266126001122
2025 Q3 37 $2.5B +9.3% 13F-HR 11/14/2025 000117266125005032
2025 Q2 34 $2.3B +17.8% 13F-HR 8/14/2025 000117266125003351
2025 Q1 33 $2B +1.5% 13F-HR 5/15/2025 000117266125002307
2024 Q4 36 $1.9B −19.1% 13F-HR 2/14/2025 000117266125001165
2024 Q3 38 $2.4B +17.6% 13F-HR 11/14/2024 000117266124005240
2024 Q2 39 $2B −6.5% 13F-HR 8/14/2024 000117266124003549
2024 Q1 42 $2.2B — 13F-HR 5/15/2024 000117266124002489
2023 Q4 40 $2B +16.3% 13F-HR 2/14/2024 000117266124001512
2023 Q3 39 $1.8B −17.4% 13F-HR 11/14/2023 000117266123004012
2023 Q2 41 $2.1B +15.9% 13F-HR 8/14/2023 000117266123003174
2023 Q1 39 $1.8B +27.4% 13F-HR 5/15/2023 000117266123002282
2022 Q4 42 $1.4B +2.3% 13F-HR 2/14/2023 000117266123001336
2022 Q3 42 $1.4B +9.8% 13F-HR 11/14/2022 000117266122002565
2022 Q2 47 $1.3B −18.3% 13F-HR 8/15/2022 000117266122002019
2022 Q1 52 $1.6B −10.0% 13F-HR 5/16/2022 000117266122001474
2021 Q4 57 $1.7B +17.2% 13F-HR 2/14/2022 000117266122000884
2021 Q3 58 $1.5B — 13F-HR 11/15/2021 000117266121002370

About

DME Capital Management

20 processed 13Fs on this site · 2021 Q3–2026 Q2

Entity
DME Capital Management
Notable person
David Einhorn
SEC filing name
DME Capital Management, LP
Location
New York, NY
All SEC filings
View on sec.gov